Knockout of miR-221 and miR-222 reveals common and specific targets for paralogous miRNAs

被引:11
作者
Jeong, Geon [1 ,2 ,3 ]
Lim, Yeong-Hwan [1 ,2 ,3 ]
Kim, Nam Joong [1 ,2 ,3 ]
Wee, Gabbine [4 ]
Kim, Young-Kook [1 ,2 ,3 ]
机构
[1] Chonnam Natl Univ, Dept Biochem, Sch Med, Gwangju, South Korea
[2] Chonnam Natl Univ, Ctr Creat Biomed Scientists, Sch Med, Gwangju, South Korea
[3] Chonnam Natl Univ, Basic Res Lab Cardiac Remodeling, Sch Med, Gwangju, South Korea
[4] Daegu Gyeongbuk Med Innovat Fdn, Daegu, South Korea
基金
新加坡国家研究基金会;
关键词
Knockout; microRNA; miR-221; miR-222; TALEN; CARCINOMA-CELL-LINES; MICRORNAS; P27(KIP1); CANCER;
D O I
10.1080/15476286.2016.1269994
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MicroRNAs (miRNAs) regulate the expression of mRNA through sequence-specific binding of the 3 untranslated region (UTR). The seed sequence of miRNAs is the key determinant for target site recognition. Paralogous miRNAs, which share the same seed sequences but differ in their 3 regions, are known to regulate largely overlapping groups of mRNAs. However, no study has analyzed functional differences between paralogous miRNAs with proper experimental methods. In this study, we compared the targets of paralogous miRNAs, miR-221 and miR-222. Using a nuclease-mediated genome engineering technique, we established knockout cell lines for these miRNAs, and precisely analyzed differences in target regulation. We found that miR-221 and miR-222 suppress the previously identified targets, CDKN1B and CDKN1C, differentially. Whereas both miRNAs suppressed CDKN1B, only miR-221 suppressed CDKN1C. From transcriptome analyses, we found that several different target mRNAs were regulated by each of miR-221 and miR-222 independently, although a large number of mRNAs responded commonly to miR-221 and miR-222. This is the first study to compare the mRNA regulations by paralogous miRNAs and illustrate that paralogous miRNAs with the same seed sequence also have difference in target regulation.
引用
收藏
页码:197 / 205
页数:9
相关论文
共 50 条
  • [31] Plasma miR-221/222 Family as Novel Descriptive and Prognostic Biomarkers for Glioma
    Zhang, Rui
    Pang, Bo
    Xin, Tao
    Guo, Hua
    Xing, Yi
    Xu, Shangchen
    Feng, Bin
    Liu, Bin
    Pang, Qi
    MOLECULAR NEUROBIOLOGY, 2016, 53 (03) : 1452 - 1460
  • [32] Targeting hepatic miR-221/222 for therapeutic intervention of nonalcoholic steatohepatitis in mice
    Jiang, Xiuli
    Jiang, Lei
    Shan, Aijing
    Su, Yutong
    Cheng, Yulong
    Song, Dalong
    Ji, He
    Ning, Guang
    Wang, Weiqing
    Cao, Yanan
    EBIOMEDICINE, 2018, 37 : 307 - 321
  • [33] Expression of MicroRNAs (miR-15b, miR-16, miR-138, miR-221, and miR-222) as Biomarkers of Endothelial Corpus Cavernosum Dysfunction in a Diabetic Alcoholic Murine Model
    Tiraboschi, Ricardo Brianezi
    Lizarte Neto, Fermino Sanches
    da Cunha Tirapelli, Daniela Pretti
    de Bessa Jr, Jose
    Miranda, Eduardo Paula
    de Assis Cirino, Mucio Luiz
    Tirapelli, Luis Fernando
    Tucci Jr, Silvio
    Fernandes Molina, Carlos Augusto
    SEXUAL MEDICINE, 2021, 9 (02)
  • [34] Cell-specific effects of miR-221/222 in vessels: Molecular mechanism and therapeutic application
    Liu, Xiaojun
    Cheng, Yunhui
    Yang, Jian
    Xu, Ling
    Zhang, Chunxiang
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2012, 52 (01) : 245 - 255
  • [35] Down-Regulation of miR-221 and miR-222 Restrain Prostate Cancer Cell Proliferation and Migration That Is Partly Mediated by Activation of SIRT1
    Yang, Xiao
    Yang, Yingmei
    Gan, Rong
    Zhao, Lingxu
    Li, Wei
    Zhou, Huaibin
    Wang, Xiaojuan
    Lu, Jianxin
    Meng, Qing H.
    PLOS ONE, 2014, 9 (06):
  • [36] MiR-221 and MiR-222 Alterations in Sporadic Ovarian Carcinoma: Relationship to CDKN1B, CDKN1C and Overall Survival
    Wurz, Kaitlyn
    Garcia, Rochelle L.
    Goff, Barbara A.
    Mitchell, Patrick S.
    Lee, Jun Haeng
    Tewari, Muneesh
    Swisher, Elizabeth M.
    GENES CHROMOSOMES & CANCER, 2010, 49 (07) : 577 - 584
  • [37] MiR-221/222 Inhibit Insulin Production of Pancreatic β-Cells in Mice
    Fan, Liwen
    Shan, Aijing
    Su, Yutong
    Cheng, Yulong
    Ji, He
    Yang, Qi
    Lei, Ying
    Liu, Bei
    Wang, Weiqing
    Ning, Guang
    Cao, Yanan
    Jiang, Xiuli
    ENDOCRINOLOGY, 2020, 161 (01)
  • [38] miR-221 and miR-222 synergistically regulate hepatocyte growth factor activator inhibitor type 1 to promote cell proliferation and migration in gastric cancer
    Ning, Tao
    Zhang, Haiyang
    Wang, Xinyi
    Li, Shuang
    Zhang, Le
    Deng, Ting
    Zhou, Likun
    Wang, Xia
    Liu, Rui
    Bai, Ming
    Ge, Shaohua
    Li, Hongli
    Huang, Dingzhi
    Ying, Guoguang
    Ba, Yi
    TUMOR BIOLOGY, 2017, 39 (06)
  • [39] miR-221/222 is the regulator of Cx43 expression in human glioblastoma cells
    Hao, Jianwei
    Zhang, Chunzhi
    Zhang, Anlin
    Wang, Kun
    Jia, Zhifan
    Wang, Guangxiu
    Han, Lei
    Kang, Chunsheng
    Pu, Peiyu
    ONCOLOGY REPORTS, 2012, 27 (05) : 1504 - 1510
  • [40] Potential Value of miR-221/222 as Diagnostic, Prognostic, and Therapeutic Biomarkers for Diseases
    Song, Jialin
    Ouyang, Yuanming
    Che, Junyi
    Li, Xiaoming
    Zhao, Yi
    Yang, Kejia
    Zhao, Xiaotian
    Chen, Yinghui
    Fan, Cunyi
    Yuan, Weien
    FRONTIERS IN IMMUNOLOGY, 2017, 8